Bruker Corporation, together with its subsidiaries, engages in the design, manufacture, sale, and service of proprietary life science and materials research systems, and associated products worldwide. It operates through two segments, Scientific Instruments, and Energy and Supercon Technologies. The Scientific Instruments segment offers instrumentation and automated solutions based on magnetic resonance, mass spectrometry, gas chromatography, X-ray, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology, and infrared and Raman molecular spectroscopy technologies. This segment serves pharmaceutical, biotechnology, and molecular diagnostic companies; academic institutions, medical schools, and other non-profit organizations; clinical microbiology laboratories; government departments and agencies; nanotechnology, semiconductor, chemical, cement, metals, and petroleum companies; and food, beverage, and agricultural analysis companies and laboratories. The Energy and Supercon Technologies segment provides superconducting materials, such as metallic low temperature superconductors for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research, and other applications; and ceramic high temperature superconductors primarily for energy grid and magnet applications. Its customers include companies in the medical industry; private and public research and development laboratories in the fields of fundamental and applied sciences, and energy research; academic institutions; and government agencies. This segment also develops superconductors and superconducting-enabled devices for power and energy grid applications, as well as for industrial processing industries. The company markets its products through direct sales force; and distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.